This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Expanding Options for the Management of IBD: Focused Updates for the IBD Care Team

Expanding Options for the Management of IBD: Focused Updates for the IBD Care Team

Format

Roundtable

Time to Complete

1.50 hours

Released

November 17, 2017

Expires

November 17, 2018
Add to Queue


Maximum Credits

1.50 / AMA PRA Category 1 CreditsTM
1.50 / CNE Contact Hours (1.50 of which is eligible for pharmacology credit)
1.50 / CPEUs for Dietitians

Accredited Provider

Provided by the Office of Continuing Medical Education, Boston University School of Medicine (BUSM), and Global Education Group.
CME and CNE accreditation provided by Boston University School of Medicine.
CDR accreditation provided by Global Education Group.

Endorsed By



Endorsed by the AGA Institute

Commercial Supporter

This educational activity is supported by an independent medical educational grant from Pfizer Inc.

Program Description

Inflammatory bowel disease (IBD) is growing on a worldwide scale and requires a high level of care to manage the substantial burden that is placed on patients. Despite improvement in treatment options, many patients do not achieve remission. Patients receiving comprehensive, team-based care have the best potential for successful treatment. With the growing number of IBD patients, gastroenterology teams that include nurse practitioners (NPs), physician assistants (PAs), dieticians/nutritionists, behavioral health professions, in addition to gastroenterologists, will be essential to provide care for the escalating patient population. All members of the GI team that encounter patients with IBD must be well informed regarding the best treatment strategies and newest treatment options that are available to patients.

Utilizing a faculty panel composed of a multidisciplinary, interprofessional, comphrehensive IBD care-team and featuring video vignettes of actual patients, the objective of this activity is to provide clinicians with the latest data regarding evolving treatment goals in IBD, adoption of an individualized treatment approach to the selection, initiation, and tailoring of biologic therapies for achieving and sustaining remission of IBD.

This program includes discussion of multiple therapies for the treatment of patients with IBD. All content has been independently developed by national experts under the direction of Boston University School of Medicine Continuing Medical Education.

Intended Audience

This activity is intended for gastroenterologists, nurses and nurse practitioners, dieticians/nutritionists, mental health professionals, and other healthcare professionals who manage adult patients with IBD.

Educational Objectives

Upon completion of these activities, participants should be better able to:

  • Determine potential causes of treatment failure for patients who are unable to achieve remission
  • Describe how to modify treatment for patients who are unable to achieve remission
  • Explain the relationship of current treatment strategies to the underlying mechanisms of disease progression in IBD
  • Discuss the safety and efficacy data for new and emerging therapeutic options for IBD, including unique mechanisms of action and potential place in therapy
  • Identify the educational needs of essential members of the IBD care team
  • Assess nutritional status and address malnutrition in the patient with IBD
  • Assess depression and anxiety in the patient with IBD

Conflict Of Interest Disclosure Policy

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Faculty

Isidore Berenbaum, MD
Director of the Psychosomatic Medicine Fellowship Program
Assistant Professor of Psychiatry
Associate Director of Consultation-Liaison Psychiatry
Boston University School of Medicine
Boston, MA

Dr. Berenbaum has no relevant financial relationships to disclose.

Francis A. Farraye, MD, MSc
Course Director
Clinical Director in the Section of Gastroenterology
Director of the Inflammatory Bowel Disease Center
Boston Medical Center
Professor of Medicine
Boston University School of Medicine
Boston, MA

Dr. Farraye discloses that he is a consultant for Abbvie, Braintree, Celgene, Ferring, Janssen, Merck, Pfizer, Salix and Takeda. He also is a stockholder for Innovation Pharmaceuticals and is on the data safety management board for Mesoblast and Protagonist.

Gail M. Gregg, MS, APRN, GNP-BC
Nurse Practitioner
Boston Medical Center
Instructor in Medicine
Department of Medicine and Gastroenterology
Boston University School of Medicine
Boston, MA

Ms. Gregg has no relevant financial relationships to disclose.

Lorraine S. Young, MS, RD, LDN, CNSC
Clinical Nutrition Manager
Boston Medical Center
Instructor in Medicine
Boston University School of Medicine
Boston, MA

Ms. Young has no relevant financial relationships to disclose.

Accredited Provider Disclosure

Lindsay Scott Borvansky, clinical content reviewer, Global Education group and planner for CPEU accreditation, has no relevant financial relationships to disclose.

Michael Burk, Senior Program Manager for Boston University School of Medicine’s Office of Continuing Medical Education, has no relevant financial relationships to disclose.

Patti-Ann Collins, Lead Nurse Planner for Boston University School of Medicine’s Office of Continuing Medical Education, has no relevant financial relationships to disclose.

Dana Frazier, Program and Grant Manager for Boston University School of Medicine’s Office of Continuing Medical Education, has no relevant financial relationships to disclose.

Andrea Funk, Senior Project Manager, Global Education Group and planner for CPEU accreditation, has no relevant financial relationships to disclose.

Karen Kaufman, Senior Project Manager, Global Education Group and planner for CPEU accreditation, has no relevant financial relationships to disclose.

Lindsay Knight, Program Manager, Global Education group and planner for CPEU accreditation, has no relevant financial relationships to disclose.

Bret Lashner, MD, planning committee member for Boston University School of Medicine’s Office of Continuing Medical Education and Professor of Medicine at the Cleveland Clinic, has no relevant financial relationships to disclose.

Beth-Ann Norton, Nursing Course Advisor for Boston University School of Medicine’s Office of Continuing Medical Education, discloses that she formerly served as a consultant for Janssen.

Laura Stinson, consultant medical editor for Boston University School of Medicine’s Office of Continuing Medical Education, has no relevant financial relationships to disclose.

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

Boston University School of Medicine designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.50

Type

CNE Contact Hour(s)

Accreditation Statement

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

CNE Contact Hours: 1.50, all of which is eligible for pharmacology credit.

Credit

1.50

Type

CPEU Credit

Accreditation Statement

Global Education Group is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR).

Designation Statement

CDR Credentialed Practitioners will receive 1.5 Continuing Professional Education units (CPEUs) for completion of this activity. CPE Provider #GE012

Disclosure of Unlabeled Use

The faculty members do not plan on discussing the unlabeled/investigational use of a commercial product.

Disclaimer

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For any CME or CNE accreditation questions please email the BUSM CME office at cme@bu.edu.

For information about the CDR accreditation of this program, please contact the Global Education Group at 303-395-1782 or cme@globaleducationgroup.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue